凝結芽孢桿菌市場規模、佔有率和成長分析：按形態、應用、最終用途、分銷管道和地區分類－2026-2033年產業預測

2024 年全球凝結芽孢桿菌市值為 9,927 萬美元，預計到 2025 年將成長至 1.0731 億美元，至 2033 年將成長至 2.01 億美元，預測期（2026-2033 年）複合年成長率為 8.1%。

全球凝結芽孢桿菌市場正經歷顯著成長，這主要得益於消費者對益生菌健康益處的認知不斷提高。這些有益菌與乳酸菌類似，因其在治療多種消化系統疾病方面的療效而聞名，包括各種類型的腹瀉、大腸激躁症(IBS)、發炎性腸道疾病（如克隆氏症和潰瘍性大腸炎）以及幽門螺旋桿菌感染疾病。其潛在的免疫增強和癌症預防功效也進一步推動了市場需求。儘管消費者對機能性食品的興趣日益濃厚，研發投入不斷增加，但市場仍面臨挑戰：消費者對其功效的認知度仍然較低。隨著消費者對健康產品的需求持續成長，新興市場為凝結芽孢桿菌提供了廣泛的發展機會。

全球凝結芽孢桿菌市場成長要素

全球凝結芽孢桿菌市場正經歷顯著成長，尤其是在化妝品行業。這主要歸功於其在改善痤瘡和各種皮膚問題方面的顯著功效。化妝品製造商正著重宣傳凝結芽孢桿菌的抗衰老特性，並開發含有該成分的創新產品。這些產品涵蓋面膜、乳液、磨砂膏、凝膠、乳霜和潔面乳等多種品類。此外，人們對含有藥用化妝品的藥妝成分的開發也越來越感興趣，這些成分被添加到各種化妝品配方中，例如乳霜和粉末。該成分擴大被用於緩解異位性皮膚炎和濕疹的症狀，其在保濕乳液和痤瘡洗面乳中的應用也日益廣泛。因此，其在個人保健產品中的保護作用也日益凸顯。

全球凝結芽孢桿菌市場的限制因素

全球凝結芽孢桿菌市場面臨許多挑戰，可能影響其成長。雖然這種益生菌通常被認為副作用極小，但濫用仍可能引起腸胃脹氣等不適。此外，由於凝結芽孢桿菌並非人體消化器官系統的天然菌叢，其安全性一直備受爭議，人們對潛在風險和副作用的擔憂也日益加劇。而且，並非所有凝結芽孢桿菌菌株都適合用作益生菌，這限制了其應用範圍。其孢子遷移至其他器官的可能性也構成額外風險，尤其對於免疫力者或體內留置導尿管者而言，這會增加細菌感染的風險。

全球凝結芽孢桿菌市場趨勢

全球凝結芽孢桿菌市場正經歷顯著成長，這主要得益於健康意識增強的消費者對無乳製品益生菌的需求不斷成長。純素和純素食者人數的快速成長，以及人們對乳糖不耐受和牛奶蛋白過敏的認知不斷提高，使得凝結芽孢桿菌成為開發無乳製品的關鍵成分。其安全性已獲得美國食品藥物管理局 (FDA) 和歐洲食品安全局 (EFSA) 等監管機構的認可，進一步提升了其市場吸引力。此外，這種益生菌即使在熱處理條件下也能保持穩定，因此易於添加到機能性食品和膳食補充劑中。其成本成本績效也使其成為食品業極具潛力的替代品，進一步推動了市場擴張。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球凝結芽孢桿菌市場規模：依形態分類

• 粉末
• 膠囊
• 藥片
• 液體
• 顆粒
• 其他

全球凝結芽孢桿菌市場規模：依應用領域分類

• 營養補充品
• 功能性食品和飲料
• 飼料和飼料添加劑
• 製藥
• 嬰幼兒營養食品
• 其他

全球凝結芽孢桿菌市場規模：依最終用途分類

• 對人類而言
• 動物
• 工業和商業用途

全球凝結芽孢桿菌市場規模：依分銷管道分類

• 直銷（B2B）
• 線上零售
• 藥局/藥局
• 超級市場和大賣場
• 專賣店
• 其他

全球凝結芽孢桿菌市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Kerry Group plc
• Sabinsa Corporation
• Lallemand Inc.
• Chr. Hansen Holding A/S
• Novozymes A/S
• DuPont de Nemours, Inc.
• Archer Daniels Midland Company
• BioGaia AB
• Probi AB
• Lonza Group AG
• Mitsubishi Chemical Group Corporation
• Sanzyme Biologics Private Limited
• Unique Biotech Limited
• Nebraska Cultures Inc.
• UAS Laboratories LLC
• Aumgene Biosciences Private Limited
• Syngen Biotech Co., Ltd.
• Mystical Biotech Private Limited
• Probiotical SpA
• Bioriginal Food & Science Corp.

結論與建議

Global Bacillus Coagulans Market size was valued at USD 99.27 Million in 2024 and is poised to grow from USD 107.31 Million in 2025 to USD 200.1 Million by 2033, growing at a CAGR of 8.1% during the forecast period (2026-2033).

The global Bacillus coagulans market is witnessing significant growth, driven by the rising consumer awareness of health benefits associated with probiotics. This beneficial bacteria, analogous to lactobacillus, is recognized for its therapeutic role in treating various digestive disorders, including all types of diarrhea, irritable bowel syndrome (IBS), inflammatory bowel diseases like Crohn's disease and ulcerative colitis, as well as infections like Helicobacter pylori. Its potential to enhance immune function and help prevent cancer further fuels demand. The increasing focus on functional foods and heightened R&D investments act as catalysts for market expansion, despite challenges posed by limited consumer awareness regarding its effectiveness. Emerging markets present promising opportunities for Bacillus coagulans, as demand for health-focused products continues to grow.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bacillus Coagulans market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bacillus Coagulans Market Segments Analysis

Global Bacillus Coagulans Market is segmented by Form, Application, End Use, Distribution Channel and region. Based on Form, the market is segmented into Powder, Capsule, Tablet, Liquid, Granules and Others. Based on Application, the market is segmented into Dietary Supplements, Functional Food & Beverages, Animal Feed & Feed Additives, Pharmaceuticals, Infant Nutrition and Others. Based on End Use, the market is segmented into Human Use, Animal Use and Industrial/Commercial Use. Based on Distribution Channel, the market is segmented into Direct Sales (B2B), Online Retail, Pharmacies & Drug Stores, Supermarkets & Hypermarkets, Specialty Stores and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Bacillus Coagulans Market

The global Bacillus Coagulans market is experiencing significant growth, particularly in the cosmetics industry, due to its notable benefits in addressing acne and various skin conditions. Cosmetic manufacturers are formulating innovative products infused with Bacillus Coagulans, highlighting its anti-aging properties. These products include a wide range of offerings such as face masks, lotions, scrubs, gels, creams, and cleansers. Additionally, there is a growing focus on developing cosmeceutical ingredients featuring Bacillus Coagulans, which are incorporated into various cosmetic formulations, including creams and powders. The ingredient is increasingly utilized to manage symptoms of atopic dermatitis and eczema, with its presence becoming prominent in moisturizing lotions and anti-acne washes, showcasing its protective properties in personal care products.

Restraints in the Global Bacillus Coagulans Market

The global market for Bacillus Coagulans faces several challenges that may impact its growth. While this probiotic is generally associated with minimal side effects, indiscriminate dosing can lead to discomfort such as intestinal gas and bloating. Additionally, ongoing debates regarding its safety arise from the fact that Bacillus coagulans is not a natural inhabitant of the human digestive system, raising concerns about potential risks and adverse effects. Furthermore, not all Bacillus coagulans strains may be suitable as probiotics, limiting its applications. The possibility of its spores migrating to other organs poses further risks, particularly for immunocompromised individuals or those with catheters, increasing the likelihood of bacterial infections.

Market Trends of the Global Bacillus Coagulans Market

The Global Bacillus Coagulans market is experiencing significant growth driven by the increasing demand for dairy-free probiotic options amid a rising health-conscious consumer base. With the surging populations of vegans and vegetarians, alongside a greater awareness of lactose intolerance and milk protein allergies, Bacillus coagulans has emerged as a pivotal ingredient in the formulation of non-dairy products. Its safety profile endorsed by regulatory bodies like the FDA and EFSA further bolsters its appeal. Additionally, the probiotic's stability under heat processing enhances its incorporation into functional foods and supplements, while its cost-effectiveness positions it as a viable alternative in the food industry, propelling market expansion.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Bacillus Coagulans Market Size by Form & CAGR (2026-2033)

• Market Overview
• Powder
• Capsule
• Tablet
• Liquid
• Granules
• Others

Global Bacillus Coagulans Market Size by Application & CAGR (2026-2033)

• Market Overview
• Dietary Supplements
• Functional Food & Beverages
• Animal Feed & Feed Additives
• Pharmaceuticals
• Infant Nutrition
• Others

Global Bacillus Coagulans Market Size by End Use & CAGR (2026-2033)

• Market Overview
• Human Use
• Animal Use
• Industrial/Commercial Use

Global Bacillus Coagulans Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Direct Sales (B2B)
• Online Retail
• Pharmacies & Drug Stores
• Supermarkets & Hypermarkets
• Specialty Stores
• Others

Global Bacillus Coagulans Market Size & CAGR (2026-2033)

• North America (Form, Application, End Use, Distribution Channel)
  • US
  • Canada
• Europe (Form, Application, End Use, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Form, Application, End Use, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Form, Application, End Use, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Form, Application, End Use, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Kerry Group plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sabinsa Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lallemand Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chr. Hansen Holding A/S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novozymes A/S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DuPont de Nemours, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Archer Daniels Midland Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioGaia AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Probi AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mitsubishi Chemical Group Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanzyme Biologics Private Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Unique Biotech Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nebraska Cultures Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• UAS Laboratories LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aumgene Biosciences Private Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syngen Biotech Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mystical Biotech Private Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Probiotical S.p.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioriginal Food & Science Corp.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations